Publications
- Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience2023 | Faculty of Medicine in Pilsen
- 5th edition of the 2022 WHO classification of prostate cancer: changes and novelties in the "Blue Book"2023 | Publication without faculty affiliation
- The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy2021 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, First Faculty of Medicine, Second Faculty of Medicine
- Prostate cancer diagnostic algorithm as a "road map" from the first stratification of the patient to the final treatment decision2021 | Faculty of Medicine in Pilsen
- Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer2020 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, First Faculty of Medicine, Second Faculty of Medicine
- Possibilities of using prostate specific membrane antigen (PSMA) ligands in the diagnosis and treatment of prostate cancer2020 | Faculty of Medicine in Pilsen
- Utilization of Prostate Health Index in prediction of prostate cancer aggressiveness2019 | Faculty of Medicine in Pilsen
- Inguinal hernia repair and laparoscopic radical extraperitoneal radical prostatectomy2019 | Faculty of Medicine in Pilsen
- The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6-A Study on 320 Patients After Radical Prostatectomy2018 | Faculty of Medicine in Pilsen
- Fusion targeted biopsy - our results and experience2018 | Faculty of Medicine in Pilsen
Loading network view...